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Sensory irritationDue largely to the controversy concerning the potential human health effects from exposure to formal-
dehyde gas in conjunction with the misunderstanding of the well-established equilibrium relationship
with its hydrated reaction product, methylene glycol, the concept of chemical equivalence between these
two distinctly different chemicals has been adopted by regulatory authorities. Chemical equivalence
implies not only that any concentration of methylene glycol under some condition of use would be nearly
or completely converted into formaldehyde gas, but also that these two substances would be toxicolog-
ically equivalent as well. A relatively simple worst case experiment using 37% formalin (i.e., concentrated
methylene glycol) dispels the concept of chemical equivalence and a review of relevant literature dem-
onstrates that methylene glycol has no inherent toxicity apart from whatever concentration of formalde-
hyde that might be present in equilibrium with such solutions.
 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Until recently, regulations for occupational inhalation exposure
to formaldehyde (FA) gas have been based primarily on eliminating
its potential to cause sensory irritation of the eyes, nose and throat.
While carcinogenic potential is mentioned, this does not rise to the
level of ‘‘known’’ in any current workplace regulations for FA.1
These regulations, e.g., the Occupational Safety and Health Adminis-
tration (OSHA) Permissible Exposure Limit (PEL) of 0.75 ppm and
Short Term Exposure Limit (STEL) of 2 ppm for 15 min, or the Amer-
ican Conference of Governmental Industrial Hygienists (ACGIH)
Threshold Limit Value (TLV) of 0.3 ppm are based on the presump-
tion that FA gas alone, even as it escaped from formalin solutionswas the sole chemical of potential importance from a health per-
spective. This concern has now been expanded to include methylene
glycol (MG), a different chemical and little understood component of
formalin which comprises the vast majority (i.e., >99.9%) of aqueous
mixtures at room temperature which can also exist in the air as a
vapor.
This additional concern is due primarily to the controversy sur-
rounding the potential health effects from the presence of MG (or
other FA donors) as the active ingredient in certain products used
in salons (e.g., keratin hair smoothing treatments) and the require-
ment for heat when such products are used. Attention about the
use of these products has focused on potential FA exposure and
sensory irritation of the eyes, nose and throat to either hair stylists
or their customers.2 Sporadic reports of sensory irritation occurring
in conjunction with the use of hair smoothing products have been
attributed solely to the presence of airborne FA gas emitted when
these products are heated as part of the process. For example, an
air monitoring study of FA emissions was conducted by Oregonure (e.g.,
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ment was conducted over the course of the day. The 8-h time
weighted exposures (TWA) ranged from 0.006 ppm to 0.33 ppm
while short-term (15 min, STEL) exposures ranged from 0.11 ppm
to 1.88 ppm with the highest STEL below the OSHA PEL of
2.0 ppm. While none of these values exceeded the OSHA PEL several
15 min. STEL measurements exceeded the ACGIH TLV value of
0.3 ppm.
Similar ﬁndings have been reported at other salons, i.e., few
exceeding the OSHA values but some in excess of the ACGIH TLV
level of 0.3 ppm. For example, a recent review by Boyer et al.
(2013) on the safety of FA and MG as used in hair smoothing prod-
ucts summarized additional air monitoring conducted in various
salons and the extent to which different exposure guidelines were
exceeded. While the OSHA PEL was exceeded in some instances, it
is important to note, as pointed out by Boyer et al. (2013) virtually
all of the emissions data summarized were based on the use of
products formulated with 10% MG as the active ingredient. As
described in the present review, with all hair smoothing products
now formulated with no more than 3%MG, the FA emissions would
be expected to be substantially reduced since FA in air samples is
directly related to concentrations in bulk products.
As a precautionary response to concerns about the potential for
hair stylist and consumer exposure to FA from MG formulated in
keratin products, the Cosmetic Ingredient Review (CIR, 2011) con-
cluded that FA and MG should be considered as essentially ‘‘equiv-
alent’’ with respect to their potential to cause FA-induced sensory
irritation. Shortly thereafter the European Commission (EC) Scien-
tiﬁc Commission on Consumer Safety and the Australian Competi-
tion and Consumer Commission (ACCC, 2012) adopted similar
positions. The practical consequences of the assumption of chemi-
cal equivalence between MG and FA is that, when heated under
actual use conditions, any concentration of MG formulated into a
product would be converted into essentially the same concentra-
tion of FA gas. This conclusion, if correct, implies not only that
MG is chemically equivalent to FA but must also be toxicologically
equivalent to FA as well. On the other hand, if the precautionary
conclusion of equivalence was incorrect suggests that current reg-
ulatory approaches would be sufﬁcient to prevent FA-induced sen-
sory irritation consistent with exposure to FA in any occupational
setting.
Because chemical equivalence between FA and MG implies that
both are functionally identical, this review will discuss the issue of
equivalence in the context of standard chemical nomenclature and
the well-established equilibrium kinetics between FA and MG. In
addition, newly developed experimental data are presented which
demonstrate that chemical equivalence cannot be conﬁrmed. In
addition, while the toxicity of FA is well understood, because
chemical equivalence between FA and MG implies toxicological
equivalence as well, the potential toxicity of MG, as contrasted
with that of FA, is also addressed.2. Background
Hair smoothing products containing MG (or other FA donors or
releasers) require the use of heat which affects the equilibrium
between FA and MG resulting in volatilization of both FA gas as
well as MG vapors. While sensory irritation of the eyes, nose or
throat has been sporadically reported by both hair stylists and cus-
tomers in conjunction with the use of hair smoothing products,
such reports appear to be the exception rather than the rule. While
hair stylists in salons are required to be trained professionals with
an understanding of how to properly use such products (similar to
other professional-use only products including peroxide hair color
or ammonia bleaches and artiﬁcial nail products, etc.) includingthe need for proper application techniques and adequate ventila-
tion, it is recognized that this may not be universally achieved.
Unlike in past years when certain products contained in excess of
10% MG, these products have now been reformulated. Currently
manufactured products are now formulated with no more than
3% MG, the minimum concentration required to achieve the
desired effect. This also substantially reduces the likelihood of sen-
sory irritation due simply to the presence of less MG (and therefore
FA) in any given product. It is noteworthy that with the thousands
of applications of these products in use each day there is a striking
lack of reports from hair stylists or customers reporting the typical
pungent odor of FA which often, but not always, precedes symp-
toms of sensory irritation (ATSDR, 1999; Golden, 2011). This sug-
gests that such products can be used without producing sensory
irritation. However, it must be noted that it is impossible to formu-
late a product, including those intended for purposes of hair
smoothing, that cannot be misused if the above noted caveats
are ignored. Hair stylists are required to follow manufacturer’s
instructions and to heed all label/product warnings. If this is not
done then most, if not all, professional products used in salons
may pose one or more potential hazards, which is why professional
use products require additional appropriate training.
It is well established that the chemical equilibrium between MG
and FA can be affected by heat with the potential for release of
higher concentrations of FA than would occur at room tempera-
tures. This has prompted a number of regulatory authorities to
conclude, without any speciﬁc evidence, that MG and FA should
be considered as chemically equivalent, i.e., that MG, under a con-
dition of actual use would be nearly or completely converted into
FA gas. This began with the Cosmetic Ingredient Review (CIR, 2011)
in deliberations about the use of MG in hair smoothing products,
‘‘. . .the ingredients formaldehyde and methylene glycol can be referred
to as formaldehyde equivalents. Under any normal condition of cos-
metic use, including at room temperature and above, methylene glycol
is not stable in the gas phase and very rapidly dehydrates to formalde-
hyde and water. . . For this reason the hazards of formaldehyde equiv-
alents in a heated solution are the same as the hazards of gaseous
formaldehyde, since the solution so readily releases gaseous formalde-
hyde.’’ This was followed by an ‘‘Opinion on Methylene Glycol’’ from
the EU Scientiﬁc Committee on Consumer Safety (2012) ‘‘. . ..the
formation of methylene glycol or the release of gaseous formaldehyde
occurs extremely quickly. Via this dynamic equilibrium in aqueous
solution, formaldehyde and methylene glycol are mutually converted
and hence inherently linked with each other due to low energy barriers
of formation and degradation of methylene glycol.’’ As discussed in
Section 5.2 the logic of this statement is demonstrably incorrect,
particularly the erroneous allegation that there is a low energy bar-
rier for the degradation of MG to FA gas implying that MG could be
quantitatively converted to FA under typical use conditions.
Finally, a similar conclusion concerning FA/MG equivalence was
reached by the Australian Competition and Consumer Commission
(ACCC, 2012), ‘‘It is proposed that ‘free formaldehyde’ could be deﬁned
as ‘all hydrated or non-hydrated formaldehyde present in aqueous
solution, including methylene glycol’.
None of the above cited pronouncements on FA/MG equivalence
are supported by any empirical data. Rather all are based on a pre-
cautionary assumption arising from concerns that MG, under the
conditions of use (i.e., heating to 400 F) in keratin smoothing
products, could release essentially the same concentration of FA
into the air as was formulated into a product as MG, i.e., that any
concentration of MG in a product could be nearly or completely
converted to FA. If true, the inescapable conclusion of the chemical
equivalence assumption would be that these two, distinctly differ-
ent chemicals would be toxicologically equivalent as well. If not
correct, this would suggest that MG and FA are not ‘‘equivalent’’
and that their potential toxicity should be considered separately.
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malin (i.e., a worse case example) demonstrate that FA and MG are
not chemically equivalent (i.e., MG is less than 50% converted to FA
under any conceivable use condition).
This review does not discuss the potential toxicity of gaseous FA
since this has been addressed in numerous other publications.
Rather, addressed are two related issues/questions since neither
has been critically assessed, i.e., (1) can FA and MG be considered
as chemically equivalent under some condition of use?, and (2)
what is the potential toxicity of MG as contrasted with FA?3. Key concepts
Before addressing the above questions it is ﬁrst necessary to
describe some basic concepts and terms to provide necessary back-
ground and context. Formaldehyde (CAS #50-00-00), as the sim-
plest aldehyde, is a highly reactive, unstable anhydrous gas with
a characteristic pungent odor, which readily binds to proteins
and DNA. As an endogenous end product of one carbon metabo-
lism, FA is present in all living organisms including humans, ani-
mals, and most foods serving as a biological reservoir for
metabolically produced FA. In the presence of liquid water or
vapors, FA reacts within 70 ms to form MG (Boyer et al., 2013).
Methylene glycol (CAS #463-57-0) a distinctly different chemical
than FA with a unique CAS number and different chemical struc-
ture, is a comparatively stable diol and part of the alcohol family.
Given these substantial chemical and biological differences, the
potential toxicity of MG is therefore likely to be very different from
that of FA.
It is well-established that in aqueous solutions, MG and FA
coexist in a dynamic equilibrium with a MG/FA ratio of 99.96:04
(i.e., 2499:1) at standard temperature and pressure (STP) and neu-
tral pH (Winkelman et al., 2000, 2002). This equilibrium, which
dramatically favors MG over FA under most conditions making
MG far more stable in comparison, does not appear to be widely
appreciated and is the source of confusion in regulatory pro-
nouncements on this issue with the landmark papers by Winkl-
eman et al. rarely, if ever, cited. For example, while the SCCS
(2012) states that there are ‘‘. . .low energy barriers of formation
and degradation of methylene glycol’’ no citations were provided
to support this assertion. However, based on the equilibrium con-
stant (Winkelman et al., 2000, 2002) the only low energy barrier is
the one which drives FA to react in the presence of water to form
MG within 70 ms (Boyer et al., 2013). Conversely, due to the com-
parative stability of MG under ambient (i.e., STP) conditions, there
is a substantial energy barrier (i.e., 2499:1) preventing it from
readily converting to FA. This explains why the majority of MG in
an aqueous solution will not be converted into FA nor will it escape
spontaneously into the air, i.e., ‘‘. . .based upon the Henry’s laws con-
stant for formaldehyde, volatilization from water is not expected to be
signiﬁcant’’ (ATSDR, 1999). In reality, to force any signiﬁcant per-
turbation of the equilibrium requires subjecting MG to unusual cir-
cumstances, e.g., drastically raising the temperature and/or
lowering the pH. The experimental results described in Section 5.2
illustrate these issues.3 Webster’s New International Dictionary, Unabridged, 2nd Ed., 1950.4. Relevant physical properties of methylene glycol and
formaldehyde
Certain physical properties of MG and FA help determine the
likelihood of inhalation exposures under varying use conditions.
In particular, this becomes an important factor at the temperatures
(i.e., 400 F) typically utilized during the use of hair smoothing
products. Due to the vapor pressure of FA (23–26 mmHg at
25 C) at ambient conditions, it is distinctive pungent odor isreadily detectable even as trace amounts escaping from formalin
solutions. Because the vapor pressure of MG (0.12 mm at 25 C)
is much lower than that of FA, under ambient conditions this pre-
vents release of large quantities of MG into the air via evaporation.
Because of the highly reactive nature of FA gas and, as sup-
ported by the equilibrium constant (Winkelman et al., 2000,
2002), when exposed to high levels of moisture in liquid or vapor
a rapid milliseconds reaction leads to formation of MG, a signiﬁ-
cantly more stable equilibrium species. Therefore, based on the
data reported and discussed in Section 5.4 conﬁrms that when
exposed to sufﬁciently high humidity, gaseous FA in air, particu-
larly at elevated temperatures, results in the rapid formation of
MG vapor in equilibrium with lesser amounts of FA gas. This is also
conﬁrmed by atmospheric data demonstrating that airborne FA gas
exposed to atmospheric cloud water vapors will form MG vapors
which react with hydroxyl radicals to create formic acid. (ATSDR,
1999) As conﬁrmation of the above phenomenon, when either
MG-containing products or formalin are heated to 400 F, both
FA and MG are vaporized along with water. This has been indepen-
dently veriﬁed by Little (1999) and Gold et al. (1984) both of whom
reported volatilizing formalin and capturing, identifying and
measuring MG in the air using the speciﬁc derivatizing agent
N,O-bis-(trimethylsilyl) triﬂuoroacetamide (BSTFA), and gas chro-
matography mass spectrometry (GCMS), thus demonstrating that
MG is stable and can exist in the vapor phase. This was further con-
ﬁrmed with two MG-containing keratin smoothing products and a
sample of 37% formalin which were individually vaporized and
tested as described above by drawing the resulting vapors through
a tube containing BSTFA/glass wool. Methylene glycol and several
of its short chain oligomers were readily identiﬁed in the vapor
phase (Analytical Sciences, 2011).5. Potential chemical equivalence of formaldehyde and
methylene glycol
Chemical equilibrium applies to reactions that can occur in both
directions and even though reactants are constantly forming prod-
ucts and vice versa the amount of reactants and products eventu-
ally reaches steady state. When the net change of products and
reactants is zero the reaction has reached a dynamic equilibrium.
The deﬁnition for a dynamic equilibrium (such as exists between
FA and MG) is when the amount of products and reactants are con-
stant (i.e., not equal but constant since both reactions are still
occurring). However, by introducing a third reactant, with the
potential to react with one of the original reactants, can disrupt
the dynamics of the original equilibrium. As discussed in Sec-
tion 5.2, this is what occurs when a derivitizing agent such as
2,4-dinitrophenylhydrazine (DNPH) with a high afﬁnity for FA,
but none for MG, is introduced into a system. In this situation, a
competing equilibrium, now between FA and DNPH, removes FA
(which did not originally exist in the vapor phase) from the system
with the net effect of disrupting the FA:MG equilibrium by pulling
FA away from MG. This is conceptually illustrated in Fig. 1 which
shows the destabilizing effects of heat and DNPH on the FA:MG
equilibrium. In the vapor phase, both FA and MG behave as they
did in solution to the extent that as FA gas reacts with DNPH, this
drives MG toward the formation of FA, which continues until the
supply of MG is diminished or exhausted. In this way, MG can be
misreported as FA in both the water and vapor phase.
The presumption that MG is equivalent to FA does not fulﬁll the
simplest chemical deﬁnition of ‘‘equivalent’’ as ‘‘having the same
combining or reacting value’’.3 Furthermore, according to the ‘‘Com-
pendium of Analytical Nomenclature’’ published by the International
Formaldehyde Methylene glycol
Fig. 1. Illustration of FA:MG equilibrium and disruption by heat and DNPH.
R. Golden, M. Valentini / Regulatory Toxicology and Pharmacology 69 (2014) 178–186 181Union of Pure and Applied Chemistry (IUPAC, 2014) Analytical
Chemistry Division, an authoritative source on chemical deﬁnitions
and nomenclature, the concept of ‘‘chemical equivalence’’ does not
include equilibrium reactions between two species and conse-
quently use of this terminology is inappropriate from a chemical
point of view for FA and MG. Therefore, for these reasons and sup-
ported by the empirical data described in Section 5.2, it is scientiﬁ-
cally inappropriate by internationally accepted convention to refer
to MG and FA as ‘‘equivalent.’’ When hair smoothing products were
initially developed (some of which were formulated with MG in
excess of 10%) there were reports of sensory irritation in conjunction
with their use. This likely played a role in the adoption of the precau-
tionary approach of equivalence between FA and MG for regulatory
purposes in the absence of appropriate data (i.e., that any concentra-
tion of MG formulated into a product could be quantitatively con-
verted to FA upon heating.) However, as with any other chemical
regulatory issue, evidence-based safety assessments should be fol-
lowed when empirical data demonstrate that a precautionary pre-
sumption is unnecessary.5.2. Testing the chemical equivalence assumption: quantiﬁcation of the
percent conversion of methylene glycol to formaldehyde
To test the equivalence hypothesis as to whether MG does or
does not undergo complete or nearly complete conversion to FA
at elevated temperatures, a relatively simple study was conducted
to determine what percentage of the MG in a standardized 37% for-
malin solution, when rapidly heated to complete vaporization, will
convert into FA gas. By using 37% formalin (i.e., 59% MG and <0.05%
FA in solution based on the equilibrium constant) this can be con-
sidered as a worst case scenario for producing the maximum con-
centration of FA that can exist in an aqueous solution as contrasted
with hair smoothing products which only contain approximately
3% MG (i.e., 0.00235% or 23.6 ppm FA). As detailed below in Sec-
tion 5.3, using the standard NIOSH Method 2016 with DPNH as
the derivitizing agent, emitted FA gas from ﬂash evaporated 37%
formalin solution was collected, derivatized and measured by high
pressure liquid chromatography (HPLC), to determine the percent
conversation of 37% MG to FA. Only if close to 100% of the vapor-
ized MG was converted to FA gas could it reasonably be concluded
that MG and FA were chemically equivalent.
To measure the actual percent conversion of MG to FA, the exact
concentrations of MG, dissolved ‘‘free’’ FA, methanol, formic acid,
as well as dimers, trimers and longer chain oligomers were directly
measured in commercial 37% formalin using 13C-NMR, 1H-NMR,
as well as standardized by titration with sodium formate. This
standardized solution of a commercial 37% formalin solution wasdetermined to contain 36.26% total releasable FA (i.e., as MG and
polymers) (Edwards, 2013).
5.3. Methods and materials
In all determinations of FA in the vapor phase personal sam-
pling pumps were calibrated to have a ﬂow rate of 0.50 l/min. Silica
gel containing sampling tubes treated with 2,4-dinitrophenylhy-
drazine (DNPH) were purchased from SKC (cat #226-119). Each
sampling tube contained a front and a back section of DNPH trea-
ted silica gel which were analyzed separately in order to determine
potential breakthrough and sampling quality. Standards of DNPH
derivatized FA were purchased from commercial companies pro-
viding certiﬁed standards for analytical testing (e.g., Restek Cat
#31837). After a typical 15 min sample collection time at 0.50 L/
min (7.5 L of air collected) the sampling tubes were capped, labeled
and organized for analysis.
Following the standard NIOSH Method 2016, analyses of FA col-
lection tubes were conducted by carefully removing the DNPH
treated front and back sections from each sampling tube and plac-
ing the DNPH treated silica gel into separate clean vials. Acetoni-
trile (2.0 ml) was volumetrically added to each vial which were
sealed with a Teﬂon lined cap, vortexed and placed in a sonication
bath for a minimum of 15 min to extract the DNPH derivatized FA.
The acetonitrile extract from each tube was placed in an autosam-
pler vial, sealed and loaded into a Hewlett Packard (Model 1100)
HPLC optimized to analyze for the DNPH derivatized FA. A Restek
ultra-aqueous C18 column (100 mm  4.6 mm ID) was utilized
with a constant acetonitrile/water (70:30) solvent mixture at a
1.0 ml/min ﬂow rate. An ultraviolet light detector was operated
at 365 nm. Ten microliters of acetonitrile extracts and standards
were injected onto the chromatographic column. A three point cal-
ibration of the HPLC instrument was performed with freshly pre-
pared DNPH derivatized FA standards at 3.33, 6.67 and 10 mg/L
concentrations.
The HPLC analysis resulted in the concentration of FA in the ace-
tonitrile extracts which was used to calculate the total amount of
FA collected in the 7.5 L of air sampled. This value was then com-
pared to the theoretical maximum amount of FA that could be
present in the air space of two containers with known volumes,
(1) a tightly sealed laboratory dry box and (2) a small sealed room.
The theoretical maximum amount of FA was calculated for the vol-
ume of air in the sampling compartment by rapidly adding a pre-
cisely measured amount of 36.26% standardized formalin
solution into an empty beaker equilibrated to 400 F. Placing the
formalin into the hot beaker resulted in complete and rapid vapor-
ization of the formalin liquid. A small fan was used in each test
chamber to ensure that adequate mixing occurred. A total of four
measurements were made with the DNPH derivatizing agent
placed at different distances in each container from the 400 F
source point where vaporization occurred. The dry box experiment
was conducted twice to ensure repeatability and reproducibility of
the results followed by the same test protocol in the sealed room to
determine any potential differences due to the size of the contain-
ment area. The DNPH derivitizing agent was placed at 6 in. in both
containers and at 16 and 36 in. from the source point where vapor-
ization occurred in the small and large containers, respectively
(Analytical Sciences, 2013).
5.4. Results
As shown in Table 1, in none of the test situations was more
than 48% of the vaporized volume of 36.26% formalin solution con-
verted into FA. Because less than half of the concentrated formalin
solution (i.e., MG) was converted to FA, MG should not be consid-
ered as equivalent to FA even at 400 F.
Table 1
Measured conversion rates of methylene glycol into formaldehyde.
Test method Container/collection
distance
Container
volume (m3)
% Conversion of
liquid MG to FA gasa
DNPH/HPLC Dry box at 6 in. 0.2724 44.3
DNPH/HPLC Dry box at 16 in. 0.2724 47.3
DNPH/HPLC Small room at 6 in. 15.18 46.5
DNPH/HPLC Small room at 36 in. 15.18 47.3
a It is unknown how much MG was directly vaporized into the air.
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ambient air following vaporization at 400 F when these vapors
are drawn into air monitoring tubes containing any derivatizing
agent (e.g., DNPH) the captured MG will be forced to convert to
FA gas to maintain the equilibrium as the DNPH removes FA from
the system thereby creating an artiﬁcial equilibrium shift. As a
result, some fraction of the MG present is consumed and misre-
ported as ‘‘formaldehyde’’, even though it did not exist as FA in
the original air sample. This is likely to skew air monitoring results
to over report FA concentrations in air samples, particularly at ele-
vated temperatures.
By necessity the results in Table 1 represent the complete con-
version of formalin (i.e., liquid MG) into FA gas, MG vapour and
water vapour indicating that when formalin is heated, only about
47% of the expected FA gas and MG vapors are produced and mea-
sured. It is not yet known what portion of this 47% comes from
directly released FA or from MG vapors absorbed onto DNPH and
reported as FA. As noted in the Analytical Sciences (2013) report,
‘‘Other formaldehyde related chemical species can be postulated to
have been formed such as methylene glycol, formaldehyde dimers or
trimers,4 as well as others which would result in an actual amount of
formaldehyde detected being less than the theoretical maximum
amount.’’ While this has yet to be determined, the Winkelman equi-
librium constant can be used to provide insights into the likely
behavior of MG when heated. According to equilibrium calculations5
the expected concentration of FA gas that can be produced when 37%
formalin is heated to 400 F should be approximately 11.3%, suggest-
ing that the contribution of MG (directly vaporized) to the values
reported in Table 1 is approximately 35% (i.e., these values would
be reduced by 65%) The likelihood that this is correct would also
appear to be conﬁrmed in a study reported by Pengelly et al.
(1996) who noted that when formalin (which contains methanol
as a preservative to prevent polymerization) is heated it forms meth-
oxymethanol which can react with derivitizing agents such as DNPH
to yield FA concentrations higher than actually present. As discussed
in Section 4, the detection of MG vapors (Analytical Sciences, 2011)
following volatilization of 37% formalin is consistent with this
interpretation.6. Potential toxicological equivalence of formaldehyde and
methylene glycol
6.1. Methylene glycol and formaldehyde in living organisms
Before considering the potential toxicity of MG its ubiquitous
presence in all living systems is ﬁrst addressed. Methylene glycol
exists in equilibrium with FA which is produced as a metabolic
by-product as part of one carbon metabolism. Formaldehyde4 1,3-Dioxetane [CAS 61233-19-0] and 1,3,5-trioxane [CAS#110-88-3],
respectively.
5 The Arrhenius equation, kh = e  Ea/(RT), demonstrates the effect of temperature
on the equilibrium between MG and FA. When formalin is heated to 400 F (477 K),
kh = e((3769/T)  5.494) 0.078248 1/kh  100 = 9.03% is the amount of available MG
expected to convert to FA gas. At 425 F, the conversion rate to FA gas is expected to
be approximately 11.31%.serves as a well-documented source of methyl groups, which are
transferred via tetrahydrofolate into the one-carbon pool for incor-
poration via biosynthesis into various macromolecules (IARC,
2009; Dhareshwar and Stella, 2008).
With respect to the disposition of exogenous FA, following 6 h
inhalation exposure to 13.1 ppm [C14]FA in F344 rats, 40% of
inhaled 14C was eliminated as [C14]carbon dioxide, 17% was
excreted in the urine as [C14] formate, 5% was eliminated in the
feces and 35–39% of 14C remained in tissues (Heck et al., 1983).
Notably none of the above noted ‘‘fates’’ of inhaled [14C] FA are
FA gas per se, but rather the 14C is incorporated into other mole-
cules such as CO2, formate or irreversibly bound to proteins. It
appears likely that MG in living systems is the direct result of met-
abolically produced FA equilibrated with body (or plant) water. In
animals the high enzymatic activity of formaldehyde dehydroge-
nase (FDH) in the upper respiratory tract metabolizes FA gas rap-
idly and efﬁciently. As demonstration of this, following
Inhalation of FA, even up to 6 ppm for 6 h/day, 5 days/week for
4 weeks in non-human primates did not change FA/MG concentra-
tions in the blood (Casanova et al., 1988). Similar ﬁndings in
humans and rats conﬁrm that inhalation of FA does not change
endogenous FA/MG blood concentrations (Casanova et al., 1988;
Heck et al., 1985). Furthermore, inhalation studies in rats and
non-human primates demonstrate that up to 10 ppm (6 h/day) of
the stable isotope 13CD2-FA for up to 5 days did not reach any
internal target organs distal to the nose as determined by the
inability to detect 13CD2-FA-DNA adducts in all tissues examined
(Lu et al., 2010; Moeller et al., 2011). The lack of potential for sys-
temic toxicity from inhaled FA suggests that irritant effects to the
eyes, nose and throat are the primary adverse health effects of con-
cern. A simpliﬁed illustration of FA biological reactions and metab-
olism is shown in Fig. 2.7. Potential toxicity of methylene glycol
While the health effects of anhydrous FA gas are well under-
stood and extensively characterized, those of MG are not. This is
due primarily to the fact that properly designed experimental stud-
ies (in both animals and humans) can be readily conducted on FA
gas alone with no potential confounding from MG. However, it is
essentially impossible to study MG as a stand-alone chemical
since, by deﬁnition it is always in equilibrium with trace (e.g., bio-
logical systems) to larger amounts (e.g., formalin) of FA.
Consequently, the only data available from which to assess or
deduce potential health effects from MG following ingestion or
inhalation exposures are those studies in which 37% formalin (con-
sisting of 59% MG and 0.05% dissolved FA based on the equilibrium
constant) is used and/or abused by humans or administered to ani-
mals. These studies are primarily of the following two types: (1)
studies of oral exposure to 37% formalin, either from suicide
attempts or controlled animal studies or (2) inhalation studies of
embalmers, anatomists or students where formalin is used. How-
ever, due to the lower volatility of MG at STP, these latter type of
studies will only involve potential exposures to FA with essentially
no exposure to MG. While inhalation exposure is the primary route
of potential concern, it is important to emphasize that because
inhaled FA neither enters the body to change endogenous concen-
trations nor reaches any potential target organs distal to the nose,
the only way to infer the potential toxicity from MG is from the
oral exposure route. Furthermore, the oral exposure studies are
more informative since larger exposure dosages can be achieved.
In assessing the oral exposure studies it is obligatory to separate
any potential adverse effects caused by MG from those attributable
to FA. Because the effects of FA, whether inhaled or ingested, have
been extensively reported, it is possible to ‘‘subtract’’ such effects
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Fig. 2. Simpliﬁed illustration of formaldehyde metabolism and disposition.
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determine the potential effects of MG, if any. If all reported adverse
effects can be reliably attributed to FA, this would provide corrob-
orating evidence that MG was without observable toxicity. Con-
versely, if there were reported effects not attributable to FA, this
would constitute presumptive evidence that such effects may be
due to MG exposure.
7.1. Oral exposure to formalin
There are two types of studies and/or data in which oral expo-
sure to MG can be reliably documented; (1) human case reports in
which formalin was either used in an intentional suicide attempt
or accidentally ingested and (2) subchronic (i.e., 4 weeks) to
chronic (i.e., 2 years) animal studies where the effects of FA are sys-
tematically investigated following gavage or drinking water/die-
tary exposures with various dilutions of formalin. Because all of
the animal studies identify No Observed Adverse Effect Levels
(NOAEL) related solely to various FA-induced corrosive lesions of
the gastric mucosa (e.g., Tobe et al., 1989; Johannsen et al., 1986;
Til et al., 1988) with no indication of the severe metabolic acidosis
discussed below, they are not reviewed. However, recognizing that
>99% of the formalin doses used in these studies was MG, it should
be noted that the NOAEL for the shortest duration study was
10 mg/kg (i.e., equivalent to approximately 500 mg/kg for a 50 kg
person), demonstrating the lack of any toxicity. Instead, the human
studies, with much higher formalin doses, are more than sufﬁcient
to assess the potential oral toxicity of formalin and therefore MG.
These are brieﬂy reviewed with a description of the reported
effects and an evaluation of whether all such effects can be reliably
attributed to FA or conversely, if some effects are plausibly due to
MG.7.1.1. Human case reports
Because of its unpleasant odor and highly corrosive properties,
intentional ingestion of 37% formalin is not a common method
used in suicide attempts. However, there are a sufﬁcient number
of case reports that can be used to assess the oral toxicity of con-
centrated formalin. Depending on the dose of 37% formalin
ingested, all case reports describe varying degrees of severe corro-
sive injuries of the esophagus and gastric mucosa similar to those
produced by strong acids. Additionally, since the FA component of
formalin is rapidly absorbed into the circulation from the gastroin-
testinal tract and metabolized to formic acid in the liver and red
blood cells, metabolic acidosis is reported in virtually all cases. This
is a typical consequence following suicide attempts due to the
inability of the body to rapidly accommodate and/or excrete the
sudden large quantities of formic acid in the circulation. Because
formic acid-induced metabolic acidosis is typically severe (and dif-
ﬁcult if not impossible to control), this results in numerous other
life-threatening signs and symptoms including chest pain, heart
palpitations, arrhythmias (ventricular tachycardia) and/or low
blood pressure, nausea, vomiting, abdominal pain, breathing
abnormalities, neurological symptoms (e.g., lethargy, stupor, coma,
seizures) and death (Isselbacher et al., 1994; Pandey et al., 2000).
For example, as reported by Köppel et al. (1990) in two separate
suicide attempts, a 55-year-old woman and a 34-year-old man
ingested unknown amounts of formalin. The female patient was
found comatose, in shock (blood pressure 50 mmHg), with respira-
tory insufﬁciency, and metabolic acidosis. Similarly, the male
patient also exhibited shock (blood pressure 60 mmHg), respira-
tory insufﬁciency, and metabolic acidosis. Analysis of the formalin
samples ingested by both patients failed to detect methanol, even
though this was expected and no other drugs or methanol were
found in their systems. Both individuals died from cardiac failure.
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as conﬁrmed by no detection of elevated methanol in their bodies
suggests that this component of formalin plays an inconsequential
role in its ultimate toxicity proﬁle. Furthermore, since methanol
(which is present in most formalin solutions as a preservative to
prevent polymerization) is also metabolized to formic acid (EPA,
2009), its role in systemic toxicity would be indistinguishable from
that produced by formaldehyde.
With minor and inconsequential variations on the above
reported cases, depending on the dose ingested and the extent to
which clinical chemistry was considered, described and/or
assessed, none of the other numerous cases of ingested formalin
report any symptoms that are not a direct result of FA (e.g., corro-
sive injuries of the esophagus and gastric mucosa and severe met-
abolic acidosis) or sequelae from these initial symptoms (Eells
et al., 1981; Hawley and Harsch, 1999; Yanagawa et al., 2007;
Nishi et al., 1988; Burkhart et al., 1990; Spellman, 1983; Bartone
et al., 1968; Watt, 1912; Kochhar et al., 1986; Heffernon and
Hajjar, 1964; Roy et al., 1962).
7.1.2. Oral exposure to formic acid
Further conﬁrmation that FA alone, with no potential contribu-
tion from MG, is responsible for all reported symptoms resulting
from formalin ingestion is provided by the numerous case studies
and reports of formic acid ingestion, again for suicidal purposes.
Rajan et al. (1985) document the clinical sequelae in 53 cases fol-
lowing intentional ingestion of formic acid. Symptoms reported
included adverse effects on the respiratory system due to inhala-
tion pneumonitis and the cardiovascular and renal systems with
both increased and decreased heart rate, arrthythmias, vascular
hypotension, hematuria, tubular necrosis and renal failure, all con-
sistent with severe metabolic acidosis identical with the same
symptoms reported following formalin ingestion. Similar reports
by Dalus et al. (2013), Sigurdsson et al. (1993) and Naik et al.
(1980) also document the key etiologic role played by metabolic
acidosis in the pattern of symptomatology leading to severe mor-
bidity or death.
It can be concluded, therefore, that following ingestion of for-
malin solutions, all reported symptoms can be reliably attributed
to formic acid, the sole FA metabolite, with no evidence or sugges-
tion that MG itself played an etiological role. This is corroborated
by the numerous case reports of identical symptoms produced fol-
lowing ingestion of formic acid with no possibility that MG was
even present. Based on these data, it is reasonable to conclude that
MG is not toxic, particularly in comparison with FA. This is con-
ﬁrmed by the animal studies (e.g., Tobe et al., 1989; Johannsen
et al., 1986; Til et al., 1988) in which far less concentrated formalin
solutions are administered orally via ingestion or gavage with no
indication of the severe metabolic acidosis produced in the forma-
lin (or formic acid) ingestion suicide case reports.
7.1.3. Oral exposure to ethylene glycol
Relevant inferences on the potential toxicity of MG can also be
augmented from data on its closest structural relative, ethylene
glycol. As discussed in this review, there is no evidence that MG
has any inherent toxicity, either systemically or topically, apart
from that attributable to FA. This can be illustrated by comparing
MG (CH2OH2) with ethylene glycol (C2H4OH2) the chemical most
closely related to it differing by only one carbon atom. As docu-
mented in this review, the systemic toxicity of high concentrations
of MG in ingested 37% formalin is due solely to the FA component
existing in equilibrium which is absorbed, metabolized to formic
acid by aldehyde dehydrogenase (ADH) in red blood cells and liver.
If the concentration of formic acid in the blood exceeds the excre-
tion capacity of the kidneys it accumulates in the circulation ulti-
mately leading to metabolic acidosis. On the other hand, thetoxicity of ethylene glycol is speciﬁcally due to this chemical
which, once absorbed from the gastrointestinal tract, is metabo-
lized by alcohol dehydrogenase (ADH) to glycolaldehyde which is
further oxidized to glycolic acid the accumulation of which in the
blood leads to metabolic acidosis. Additional renal toxicity of eth-
ylene glycol results from a direct cytotoxic effect of glycolic acid on
the kidneys, not ethylene glycol itself. Subsequent metabolism of
glycolic acid leads to glyoxylic acid and ﬁnally to oxalic acid which
can crystallize in many areas of the body including the brain, heart,
lungs and kidneys causing additional damage (ATSDR, 2010). The
data on ethylene glycol demonstrate that metabolites of this chem-
ical are the direct cause of its toxic effects. In contrast, the data for
MG are unambiguous that it is not this compound (which is endog-
enous to the body) that causes toxicity, but rather whatever con-
centration of FA that might be present in equilibrium with it that
is the direct cause of its systemic effects. Finally, there is no evi-
dence that MG serves as a substrate for alcohol dehydrogenase
since the sole purpose of this chemical (1) provides the ‘‘buffering
capacity’’ to prevent accumulation of FA in the blood, and (2) can-
not exist in biological systems in the absence of metabolically pro-
duced FA.8. Inhalation exposure studies
The most relevant studies of inhalation exposures to formalin
involve workers with high potential for exposure, such as embalm-
ers and/or in gross anatomy/dissection labs where formalin (rang-
ing from 10 to 37%) is typically used. Due to its volatility, FA readily
escapes as attested by the numerous studies in which sensory irri-
tation is reported in conjunction with these occupations. However,
the signiﬁcantly lower vapor pressure of MG suggests much less
potential for volatilization at ambient temperatures. Despite the
diversity of populations in these studies it is notable that other
than reports of sensory irritation of the eyes, nose and throat, as
well as nausea, headache, transient breathing difﬁculties,
decreased ability to smell, dry mouth and dermal sensitization,
no other adverse effects are reported consistent with FA as the sole
causative agent (Holness and Nethercott, 1989; Chia et al., 1992;
Mirabelli et al., 2011; Takahashi et al., 2007; Khaliq and Tripathi,
2009).9. Conclusions
The precautionary principle is intended to apply to situations
where there is considerable scientiﬁc uncertainty concerning the
potential health effects of a particular chemical. However, it is
not a substitute for evaluating potential health or environmental
effects when sufﬁcient information exists as it does for FA and
MG. While it may have been initially prudent, given the general
lack of understanding concerning the FA:MG equilibrium, particu-
larly the effects of heat on such systems, the precautionary conclu-
sion of equivalence can now be reevaluated with empirical data.
Notwithstanding that FA and MG are two distinctly different
chemical species, the fact that less than half of a 37% formalin solu-
tion (a worst case scenario) can be ‘‘converted’’ to FA following
ﬂash evaporation at 400 F suggests that the equivalence assump-
tion should be replaced by evidence-based considerations.
As summarized in this review FA and MG are not equivalent,
either chemically or toxicologically. This is not surprising given
that FA is a highly reactive anhydrous gas in the aldehyde family
while MG is orders of magnitude less reactive (if at all), is generally
a liquid and in the alcohol family. With the established equilibrium
between MG and FA strongly favoring the former over the latter by
a ratio of 99.96:0.04 (i.e., 2499:1) under STP conditions, there does
not appear to be an actual use scenario in which MG could be
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tal data showing that less than half of a 37% formalin solution was
converted to FA upon vaporization at 400 F. The presumption of
equivalence has been adopted by various regulatory authorities
out of an abundance of caution and due to reasonable precaution-
ary concerns about the use of MG in certain products designed to
be heated. However, since <50% of a vaporized formalin solution
was converted to FA gas the presumption of chemical equivalence
is unsupported by empirical data.
Toxicological equivalence would imply that MG could exert
effects similar to or the same as FA. However, a lack of toxicological
equivalence between FA and MG is supported by extensive human
and animal data. Methylene glycol is not toxicologically similar to
FA and it is reasonable to conclude that it has essentially no toxic-
ity absent that attributable to FA present in equilibrium. As shown
by numerous case reports of suicides following ingestion of 37%
formalin or concentrated formic acid, the principal metabolite of
FA, the symptomology eventually leading to severe systemic toxic-
ity (i.e., primarily metabolic acidosis) and death can only be
ascribed to the FA component of formalin or its formic acid metab-
olite. The human case reports are supported by numerous acute,
sub-chronic and chronic animal studies with various dilutions of
formalin in which all reported symptoms, mainly adverse effects
on the gastrointestinal tract, are readily explained as a conse-
quence of the corrosive properties of FA. Together, the human
and animal data on formalin demonstrate that FA and its formic
acid metabolite, with no discernible contribution from MG, are
the sole causative agents responsible for all reported symptoms
of systemic toxicity.
Based on the available data, it appears that MG exists naturally
in living organisms as an equilibrium-based chemical/biological
reservoir for metabolically produced FA. In this role, MG likely
serves as a biological ‘‘buffer’’ to detoxify FA by limiting its concen-
tration in the body while having no inherent toxicity. Therefore,
recognizing that MG is present endogenously in equilibrium with
FA in all animals and plants and is ingested in substantial quanti-
ties as a naturally occurring constituent in food justiﬁes the con-
clusion that MG is (1) not toxic, (2) not toxicologically equivalent
to FA, and (3) not chemically equivalent to FA. In fact, in many
ways they can be considered opposites, but certainly not
equivalents.
Speciﬁcally with respect to potential inhalation exposures to
either volatilized FA or MG from the use of hair smoothing prod-
ucts which contain MG (or other FA donors) as the active compo-
nent the following key conclusions are warranted, (1) given the
relatively large NOAELs for ingested MG suggests a similar lack
of potential risk from inhalation exposure, (2) FA gas is the sole
exposure of potential concern, and (3) as long as the biological
indicator of exposure, i.e., sensory irritation of the eyes, nose or
throat, does not occur in stylists or customers and the FA emissions
are below either the OSHA standard of 0.75 ppm or the more strin-
gent value of 0.3 ppm established by ACGIH, hair smoothing prod-
ucts should be considered safe to use. As with other products used
in a salon setting (e.g., hair color or bleach, artiﬁcial nail products,
Japanese thermal straightening/smoothing products, etc.) all are
accompanied by Material Safety Data Sheets (MSDS), are sold to
salons with a requirement that hair stylists be properly trained,
that product label and instructions are heeded and that ventilation
appropriate to the work being performed in the work space is
available.
Finally, based on the data summarized in this review, it should
neither be assumed that MG and FA are equivalent nor that MG
converts 100% into FA under any condition of use. Furthermore,
it should also be recognized that because MG vapors can readily
exist in the air at relatively high concentrations following sufﬁcient
heating (low concentrations at STP) it is likely that air samplingstudies and analysis which do not account for this phenomenon
could result in over reporting of FA. Consequently, artifacts created
by vaporized MG being captured, derivitized and reported as FA
need to be addressed in order to ensure that sampling and/or ana-
lytical methods accurately quantify and report FA gas alone.
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